Chemotherapy has been found in preclinical studies to synergize with TRAIL in breast cancer cells, including doxorubicin, cisplatin, 5 fluorouracil, gemcitabine, and irinotecan, and paclitaxel [30,172]. The gene discussed is TNFSF10; the disease is breast carcinoma.